Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00000473
Recruitment Status : Completed
First Posted : October 28, 1999
Last Update Posted : December 13, 2013
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)

Brief Summary:
To determine whether a dietary supplement of n-3 polyunsaturated fatty acids (PUFAs) derived from fish oil would decrease the restenosis rate in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).

Condition or disease Intervention/treatment Phase
Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Behavioral: dietary supplements Drug: fatty acids, omega-3 Behavioral: diet, fat-restricted Phase 3

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Masking: Double
Primary Purpose: Prevention
Study Start Date : July 1989
Actual Study Completion Date : June 1994

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Angioplasty





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Men and women with coronary heart disease in the native coronary arteries. Patients were symptomatic or had 50 percent or greater stenosis as defined by coronary angiography.

Patients had not undergone prior angioplasty.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000473


Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Layout table for investigator information
OverallOfficial: Alexander Leaf Massachusetts General Hospital

Publications:
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00000473     History of Changes
Other Study ID Numbers: 62
U01HL040548-04 ( U.S. NIH Grant/Contract )
First Posted: October 28, 1999    Key Record Dates
Last Update Posted: December 13, 2013
Last Verified: April 2012
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Diseases
Coronary Disease
Myocardial Ischemia
Ischemia
Cardiovascular Diseases
Pathologic Processes
Vascular Diseases